Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.

Nat Biotechnol · 2020 · PMC7740072 · PMID 32855547

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Overall, both studies showed a trend for increased detection of SARS-CoV-2 specific antibodies with increased time from symptom onset.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.